Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

BDTXREGN

Black Diamond Therapeutics, Inc.

BDTX · $1.88

62Good

Regeneron Pharmaceuticals, Inc.

REGN · $782.04

73Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

BDTX

62/100

REGN

73/100

Quality

Is it a profitable, well-run business?

BDTX

2.0/10

REGN

6.2/10

Growth

Is the company growing?

BDTX

3.3/10

REGN

4.5/10

Valuation

Is the price reasonable? (higher = cheaper)

BDTX

6.7/10

REGN

6.9/10

Risk

How risky are the shares? (higher = lower risk)

BDTX

2.5/10

REGN

8.1/10

Momentum

Is the share price trending up?

BDTX

6.1/10

REGN

8.4/10

Financial strength

Is the balance sheet healthy?

BDTX

4.9/10

REGN

9.7/10

The balanced view

Model-generated

Black Diamond Therapeutics, Inc.

This company scores above average, with supportive analyst views and a reasonable valuation, although its profitability is thin.

Leads on: no single area

Best feature: analysts broadly positive (Analyst buy share: 91%)

Watch out: profitability is thin (Return on equity (TTM): -38.8%)

Regeneron Pharmaceuticals, Inc.

This company scores above average, with a healthy balance sheet and a positive price trend.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: healthy balance sheet (Altman Z-Score: 7.29)

Watch out: weakest area: growth potential (Revenue growth (FY): 1.0%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.